Deutsche Bank
JAZZ icon

Deutsche Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Deutsche Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-76
Closed -$9K – 4987
2016
Q3 		$9K Hold
76
– – ﹤0.01% 4684
2016
Q2 		$10K Buy
+76
New +$11.2K ﹤0.01% 4908
2016
Q1 		– Sell
-76
Closed -$10K – 5243
2015
Q4 		$10K Buy
+76
New +$10.5K ﹤0.01% 4922

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deutsche Bank's JAZZ Position: Q1 2026 in Review

Deutsche Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 82% in Q1 2026, selling an estimated $20.1M and leaving 25,273 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Deutsche Bank first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $58M in Q2 2016. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Deutsche Bank held 25,273 shares of Jazz Pharmaceuticals worth $4.78M as of Q1 2026.
  • Deutsche Bank sold 115,013 Jazz Pharmaceuticals shares in Q1 2026, an estimated $20.1M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1315 holding.
  • Deutsche Bank first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Jazz Pharmaceuticals position peaked at $58M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.